Overview
Genpharmasec Limited, established in 1992, is primarily engaged in pharmaceutical activities and trading in equity shares, initially focusing on chemicals and pigments manufacturing.
The company pivoted in 2018 towards pharmaceuticals and ventured into securities trading, marking a strategic shift in operations.
In 2019, Genpharmasec entered the medical device segment, securing distribution rights for Abbott's diagnostic equipment, a move aimed at diversification.
Recently, the company enhanced profitability by importing Abbott cartridges directly, cementing its position in the diagnostic equipment distribution sector.
With consistent efforts to expand beyond single partnerships, Genpharmasec is actively seeking growth opportunities to avoid sales stagnation.
- Sector
Trading
- Industry
Trading - Medium / Small
- Market Cap
63 Cr
- Volatility
Low Risk
- P/E Ratio
-37.7
- Industry P/E
37.2
- PEG Ratio
—
- P/B Ratio
1.0
- 52W High
2.40
- 52W Low
0.98
Financial Ratios
Sales CAGR
- 1Y
- 10.88%
- 3Y
- 6.46%
- 5Y
- 14.84%
- 10Y
- —
Profit CAGR
- 1Y
- 823.53%
- 3Y
- —
- 5Y
- 19.59%
- 10Y
- 42.96%
ROE
- TTM
- 0.80%
- 3Y
- 2.49%
- 5Y
- 2.57%
- 10Y
- 2.76%
ROCE
- TTM
- 2.48%
- 3Y
- 3.17%
- 5Y
- 3.13%
- 10Y
- 3.30%
Technicals
Oscillators
Bullish
Bearish
4
Neutral
2
Bullish
8
Overall
Bearish
Bearish
36
Neutral
2
Bullish
8
Moving Averages
Bearish
Bearish
32
Neutral
0
Bullish
0
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
